Market InstituteMarket Institute
  • About
    • Who We Are
  • Research & Commentary
    • Papers
  • Events
  • Issues
  • Projects
    • International Overreach: When Global Standards Become U.S. Policy
    • Alzheimer’s
    • Letters
    • Political Cartoons

Research & Commentary

Articles

Trump enabled the vaccine moonshot, but his drug price rule threatens future innovation

The Market Institute President Charles Sauer has a new piece Read more…

By admin, 6 years3 years ago
Press Release

Letter to Senate Majority Leader Mitch McConnell on “No Surprises Act”

The Market Institute joined a coalition of free market leaders Read more…

By admin, 6 years6 years ago
Articles

Is U.S. Falling Behind China In Cryptocurrency Innovation?

Market Institute President Charles Sauer is out with a piece Read more…

By admin, 6 years6 years ago
Articles

‘Trust the science,’ until the science doesn’t support the nanny state

Here’s an excerpt from the latest Washington Examiner piece by Read more…

By Jeff Cargerman, 6 years6 years ago
Articles

Destructive Union Politics Have Flourished During COVID-19

Market Institute President Charles Sauer is out with a new Read more…

By Jeff Cargerman, 6 years6 years ago
Articles

Regulators consider treating the freight rail industry like it’s 1887

The Market Institute President Charles Sauer has a new piece Read more…

By Jeff Cargerman, 6 years6 years ago
Articles

Republicans Push for Socialist Price Controls in Coronavirus Bill

The Market Institute’s Charles Sauer is out with a new Read more…

By Jeff Cargerman, 6 years3 years ago
Articles

Labor Secretary Eugene Scalia is on the Right Track with Activist Investor Reform

The Market Institute’s Charles Sauer has a new piece in Read more…

By Jeff Cargerman, 6 years6 years ago
Articles

Government May Attempt to Steal COVID Vaccine

The Market Institute’s Charles Sauer is out with a new Read more…

By Jeff Cargerman, 6 years6 years ago
Press Release

The Market Institute’s Statement on EPA

For Immediate Release: “The EPA has a documented history of underestimating the Read more…

By Jeff Cargerman, 6 years6 years ago

Posts pagination

Previous 1 … 37 38 39 Next
Recent Articles
  • A Government That’s Trying to Please You Will Make You Miserable October 16, 2026
  • How I Stopped Worrying, and Learned to Love Data Centers October 15, 2026
  • Charles Sauer: Government Policy Is Fueling Hospital Consolidation October 13, 2026
  • Patients First Act: Protecting Choice and Taxpayers October 9, 2026
  • Most Favored Nation Price Controls Disfavor Patients October 5, 2026
Recent Papers
  • The Trouble with Tariffs
  • The $135 Billion Lie: How Upcoding Is Draining Medicare and Medicaid
  • Why Does the Government Pay More for the Same Care?
  • The Practical, Constitutional, and Moral Case Against Social Media Regulation “For the Children”
  • Free Markets Under Attack from the Left and Right

Loading

By adding your phone number, you opt in to receive text messages

Facebook
Twitter
YouTube

The Market Institute Verified account Follow

We promote free market public policies. We get government out of the way.

MarketInstitute
marketinstitute

The Market Institute

Verified account @marketinstitute ·
23 Oct

Businesses should be able to succeed or fail based on how they perform, not how much the government has invested in them. A free market means letting businesses compete on their own, not having the government take a bigger seat at the table.

Stephen Moore @StephenMoore

Memo to the Trump administration: Stop buying companies.

A government $40 trillion in debt should be SELLING assets, not buying ownership stakes in 36 companies.

We thought government control of the means of production was what we were fighting against.

Reply on Twitter 2113667268819182035 Retweet on Twitter 2113667268819182035 Like on Twitter 2113667268819182035 X 2113667268819182035
marketinstitute

The Market Institute

Verified account @marketinstitute ·
23 Oct

The goal should be simple: protect national security without blocking promising medicines from reaching American patients.

Broad biotech restrictions risk doing exactly that.

Axios @axios

Trump administration proposes new curbs on China biotech deals https://www.axios.com/2026/10/23/trump-china-biotech-restrictions?utm_campaign=mrf-utm_source=x&utm_medium=organic_social&utm_campaign=editorial&utm_source=twitter&utm_medium=social&mrfcid=202610236ad04fc1adeaa64e72130b68

Reply on Twitter 2113627990798049521 Retweet on Twitter 2113627990798049521 Like on Twitter 2113627990798049521 X 2113627990798049521
marketinstitute

The Market Institute

Verified account @marketinstitute ·
23 Oct

Protecting inventors is a founding American principle. Strong patent rights give innovators the incentive to build what comes next.

As @newtgingrich puts it:

“We want to encourage inventors. We want to give them legal protection so they have an incentive.”

Reply on Twitter 2113626326032928990 Retweet on Twitter 2113626326032928990 Like on Twitter 2113626326032928990 X 2113626326032928990

  • About
  • Research & Commentary
  • Events
  • Issues
  • Projects